Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-jRCT2053190103
JPRN-jRCT2053190103Active, not recruitingPhase 1

Phase I trial of ADR-002K for patients with ischemic cardiomyopathy who undergo coronary artery bypass surgery

SAWA Yoshiki0 sites6 target enrollmentStarted: January 31, 2020Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
6
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 20age old to < 80age old (—)
Sex
All

Inclusion Criteria

  • •1) Patients who are clinically diagnosed with ischemic cardiomyopathy and receive CABG
  • •2) Patients with a left ventricular ejection fraction of 40% or less by cardiac ultrasonography within 4 weeks before obtaining consent

Exclusion Criteria

  • •1) Patients who have a combination of cardiovascular disease such as severe organic valvular disease or aortic aneurysm determined by investigator or co-investigator to affect clinical trial procedure
  • •2) Patients whose participation in a clinical trial is considered inappropriate at the discretion of the investigator or co-investigator

Investigators

Sponsor
SAWA Yoshiki

Similar Trials

Completed
Phase 1
Phase I trial of ADR-002K for patients with ischemic cardiomyopathy who undergo coronary artery bypass surgeryIschemic Cardiomyopathy
JPRN-UMIN000038809Osaka University Hospital6
Recruiting
Phase 2
A Phase 2 Study of ADR-001 in Patients with Severe Pneumonia caused by SARS-CoV-2 infectioPatients with Severe Pneumonia caused by SARS-CoV-2 infection
JPRN-jRCT2053210023Okawa Sumito20
Active, not recruiting
Phase 2
ADR-001-N1Compensated liver cirrhosis (Child-Pugh A)
JPRN-jRCT2033210425Terai Shuji9
Recruiting
Not Applicable
Phase 1b/2 trial for CKD-702 in combination with irinotecan as a third-line therapy for gastric cancer with MET or EGFR protein overexpressioNeoplasms
KCT0008025ational Cancer Center52
Active, not recruiting
Not Applicable
A randomized clinical study of stem cells taken from fat tissue in the experimental treatment of patients with myocardial infarction (heart attack)patients with ST-elevation myocardial infarction after PCI with stentMedDRA version: 14.1Level: LLTClassification code 10028597Term: Myocardial infarction acuteSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2010-022153-42-DECytori Therapeutics, Inc216